Antimetabolites: all 7,479 studies that test it
Page 65 of 75. Open to participants first (1,134), then studies with results posted, then the rest; newest registration first within each.
- Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00275119Phase 2
- Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaCompletedNCT00275080Phase 1
- Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaCompletedNCT00275054Phase 3
- Gemcitabine and Oxaliplatin in Treating Patients With Metastatic CancerStatus unknownNCT00274859Phase 2
- Amonafide in Combination With Cytarabine in Secondary AMLCompletedNCT00273884Phase 2
- Efficacy Study of GEMOX Combination and Vinorelbine in NSCL PatientsCompletedNCT00271271Phase 2
- CT-2103 in Combination With Gemcitabine in Metastatic Breast CancerCompletedNCT00270907Phase 1
- A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung CancerStatus unknownNCT00270582Phase 2
- An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric CancerStatus unknownNCT00270543Phase 2
- Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.CompletedNCT00270491Phase 2
- Hydroxyurea and Erythropoietin to Treat Sickle Cell AnemiaCompletedNCT00270478Phase 1
- The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary CancerCompletedNCT00268840Phase 2
- Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00268489Phase 2
- Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerStatus unknownNCT00268411Phase 3
- Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable MetastasesCompletedNCT00268398Phase 3
- S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the OropharynxTerminatedNCT00268372Phase 3
- Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT00268229Phase 1
- Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung CancerTerminatedNCT00268151Phase 1
- AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00265876Phase 1/2
- Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast CancerCompletedNCT00265733Phase 2
- Random Trial for Elderly Patients With NSCLCStatus unknownNCT00265694Phase 3
- Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II StudyCompletedNCT00263705Phase 2
- Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal CancerCompletedNCT00263029Phase 2
- Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00262795Phase 3
- Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaCompletedNCT00262782Phase 3
- Docetaxel in Head and Neck CancerCompletedNCT00261703Phase 2/3
- Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic CancerCompletedNCT00260364Phase 1/2
- Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLCCompletedNCT00259675Phase 2
- Oxaliplatin in Esophagus Cancer (Advanced) 1st LineCompletedNCT00259402Phase 2
- Docetaxel in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00258739Phase 2
- Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate CancerCompletedNCT00258284Phase 2
- Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous LeukemiaCompletedNCT00258271Phase 1
- Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00258232Phase 2
- D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive DisorderWithdrawnNCT00257361Phase 2
- Capecitabine and Docetaxel in Advanced/Recurrent Cervical CancerCompletedNCT00257348Phase 2
- Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction CarcinomaTerminatedNCT00256321Phase 2
- Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLCTerminatedNCT00254904Phase 3
- Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT00254319Phase 2
- Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.CompletedNCT00254137Phase 2
- Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00253565Phase 1
- Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic CancerWithdrawnNCT00253526Phase 2
- Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis SubjectsCompletedNCT00252668Phase 4
- Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural MesotheliomaCompletedNCT00251550Phase 1/2
- A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLCCompletedNCT00251524Phase 2
- Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic CancerCompletedNCT00251355Phase 1
- First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly PatientsTerminatedNCT00251186Phase 2
- Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per MicroliterCompletedNCT00250822Phase 2
- NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)CompletedNCT00248404Phase 1/2
- Safety Study of 2DG With Stereotactic RadiosurgeryWithdrawnNCT00247403Phase 1
- Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00244946Phase 1
- Methotrexate in Ankylosing Spondylitis (MTX in AS)Status unknownNCT00243750Phase 2
- Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00243100Phase 1
- Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By SurgeryTerminatedNCT00243009Phase 2
- IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo FailureCompletedNCT00242788Phase 1/2
- Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic CancerCompletedNCT00242190Phase 1/2
- A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT00241371Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal CancerCompletedNCT00238147Phase 1
- Gefitinib in Combination With Chemoradiation in Resectable Gastric CancerTerminatedNCT00237900Phase 1/2
- Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial CancerTerminatedNCT00237575Phase 3
- Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With MethotrexateCompletedNCT00235859Phase 3
- Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00235820Phase 3
- Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid ArthritisCompletedNCT00234845Phase 3
- A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal CarcinomaCompletedNCT00234429Phase 2/3
- IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic CancerCompletedNCT00234416Phase 1/2
- Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell LymphomaCompletedNCT00234026Phase 2
- Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesTerminatedNCT00234000Phase 1
- Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal CancerWithdrawnNCT00233623Phase 2
- Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid ArthritisTerminatedNCT00233558Phase 4
- Clinical Study of Previously Untreated Patients With Malignant MelanomaCompletedNCT00232726Phase 2
- Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian CancerCompletedNCT00230542Phase 2
- Combination Chemotherapy Treatments in Patients With Metastatic Colorectal CancerCompletedNCT00230399Phase 2
- IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell ImmunodeficiencyCompletedNCT00228852Phase 1/2
- Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00227734Phase 2
- Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast CancerTerminatedNCT00227656Phase 2
- Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00227630Phase 2
- Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00227565Phase 2
- A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell CarcinomaCompletedNCT00226980Phase 2
- Immunochemotherapy for Metastatic Renal Cell CarcinomaStatus unknownNCT00226798Phase 2
- Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic CancerWithdrawnNCT00226746Phase 2
- Combination Chemotherapy +/- Radiation in High Risk Hodgkin's DiseaseTerminatedNCT00225173Phase 2
- Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast CarcinomaTerminatedNCT00225056Phase 2
- Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic CancerCompletedNCT00222469Phase 2
- A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain LymphomaCompletedNCT00221325Phase 1
- Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the PancreasCompletedNCT00220649Phase 1
- A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or ThrombocytopeniaCompletedNCT00220311Phase 4
- Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI TumoursCompletedNCT00220168Phase 4
- Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal CancerCompletedNCT00220155Phase 2
- Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the OesophagusCompletedNCT00220129Phase 2
- Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal CancerCompletedNCT00220116Phase 2
- Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal AdenocarcinomaCompletedNCT00220103Phase 2
- A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI TumoursCompletedNCT00220064Phase 2
- A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal CancerCompletedNCT00220051Phase 2
- Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous PatientsTerminatedNCT00219765Phase 1/2
- Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00217711Phase 1/2
- Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00217698Phase 2
- Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT00217555Phase 2
- Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By SurgeryCompletedNCT00217542Phase 1
- Paricalcitol and Gemcitabine in Treating Patients With Advanced CancerCompletedNCT00217477Phase 1
- Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung CancerCompletedNCT00217282Phase 2
- Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or CholangiocarcinomaTerminatedNCT00216437Phase 1